Runway Growth Capital Strengthens Analytics Leadership with Avisha Khubani’s Promotion
32min read Runway Growth Capital has elevated Avisha Khubani to Managing Director of Portfolio Analytics, a move that underscores the firm’s commitment to leveraging data-driven strategies to navigate high-growth sectors like technology, healthcare, and consumer services. Khubani’s expertise in risk management and valuation—gained over seven years at Runway and prior roles at Kroll and Barclays Capital—positions her to refine the firm’s investment decision-making processes at a critical juncture for its portfolio companies.
The Rise of Avisha Khubani: A Data-First Visionary
Khubani’s promotion reflects her instrumental role in building Runway’s portfolio analytics function since joining in 2018. Her career has been marked by technical proficiency in valuing complex financial instruments, including private loans, equity, and derivatives. As Managing Director, she will oversee portfolio monitoring, risk assessment frameworks, and the performance of Runway’s 128 total investments (46 debt, 84 equity) across 83 companies as of March 2025.
Her leadership will be vital as Runway navigates sectors such as healthcare, where it recently deployed $55 million to Route 92 Medical Inc., a portfolio company refinancing its debt, and technology, where it has stakes in firms like FiscalNote Holdings. Khubani’s alignment with Runway’s “credit-first” approach—97.9% of its debt portfolio is senior secured—ensures disciplined risk management in volatile markets.
Sector Focus: Tech, Healthcare, and Consumer Services Dominate
Runway’s investments are concentrated in three sectors, each with distinct opportunities and challenges:
1. Technology
Runway prioritizes late-stage tech companies modernizing industries through AI, software, and hardware innovation. For instance, its $13 million follow-on investment in Elevate Services, Inc. (a tech-enabled consumer services firm) highlights its focus on scalable, equity-dilution-averse businesses. The sector’s resilience is reflected in Runway’s 14.7% dollar-weighted annualized yield on debt investments as of December 2024.
2. Healthcare
Healthcare remains a cornerstone, with $37.4 million in proceeds from the liquidation of Gynesonics, Inc., a medical device company, and ongoing stakes in firms like Route 92 Medical. The sector’s stability is critical as Runway aims to mitigate risks in volatile markets. CEO David Spreng praised Khubani’s role in “optimizing risk-adjusted returns,” a priority for healthcare’s capital-intensive development cycles.
3. Consumer Services
Runway’s selective focus here includes investments like Marley Spoon SE, a meal-kit service that received $2.7 million in funding. These bets align with its strategy of backing resilient, subscription-based models, which accounted for 26% of its portfolio’s equity holdings as of March 2025.
Strategic Advantages: BC Partners’ Acquisition and Portfolio Depth
The acquisition of Runway’s adviser by BC Partners Credit in early 2025 has amplified the firm’s resources, enabling deeper sector penetration. The partnership expands access to capital and industry networks, particularly in healthcare and technology—sectors where BC Partners Credit already holds expertise.
Khubani’s promotion also comes amid strong financial results: Runway reported $14.6 million in net investment income ($0.39 per share) for Q4 2024, with a core leverage ratio of 108% and $244.8 million in liquidity. These metrics underscore the firm’s capacity to sustain growth while managing risk—a balance Khubani’s analytics team will now refine.
Conclusion: A Data-Driven Path to Sustainable Growth
Avisha Khubani’s elevation to Managing Director of Portfolio Analytics is a strategic coup for runway growth Capital. Her technical acumen and institutional knowledge will be pivotal in optimizing returns across its $1.1 billion portfolio, particularly in high-potential sectors like healthcare and technology. With a 14.7% yield on debt investments and a track record of liquidity events like the $37.4 million exit from Gynesonics, Runway is well-positioned to capitalize on its focus areas.
The promotion also signals Runway’s confidence in its sector bets: healthcare’s resilience, technology’s innovation, and consumer services’ scalability are now backed by advanced analytics. As Khubani integrates AI-driven tools into portfolio monitoring, investors can anticipate sharper risk assessments and more disciplined capital deployment—a recipe for sustained success in today’s dynamic markets.
With Khubani at the helm of its analytics function, Runway is not just managing portfolios—it’s building a data-driven engine for growth.
